Addiction Science & Clinical Practice

Article	Citations
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	72
Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial	51
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment	43
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	34
Rethinking trazodone for insomnia in alcohol use disorder	34
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice	32
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	31
Comparison of heroin and fentanyl use in US nationally representative surveys	28
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary	26
Effects of morbidity on smoking cessation: a national smoking cessation program	25
Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial	24
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	22
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial	20
Correction: Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial	19
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims	19
A 13-item Health of the Nation Outcome Scale (HoNOS-13): validation by item response theory (IRT) in patients with substance use disorder	19
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review	18
Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care	17
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	16
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	16
A mobile-based pregaming drinking prevention intervention for college students: study protocol for a randomized controlled trial	15
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment	15
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs	15
The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial	14
‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians	14

Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital	14
Augmenting project ECHO for opioid use disorder with data-informed quality improvement	14
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?	13
Grayken lessons: between a rock and a hard place? A 37-year-old man with acute liver injury while enrolled in a managed alcohol program for severe alcohol use disorder	13
Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study	13
Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study	13
Efficacy of mindfulness and goal setting interventions for increasing resilience and reducing smoking in lower socio-economic groups: randomised controlled trial protocol	13
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	13
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	13
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	13
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems	12
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	12
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	12
Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study	12
How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky	11
Internet-delivered therapy for alcohol misuse: engagement, satisfaction, and outcomes when patients select their preference for therapist- or self-guided treatment	11
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	10
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England	10
Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	10
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	10
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	10
Normalizing fentanyl: interpreting the perceived ‘risk’ of correctional officer work	9
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	9
Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals	9
Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey	9
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic	9
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting	8
Psychometric assessment of the Moroccan version of the car, relax, alone, forget, friends, trouble (CRAFFT) scale among adolescent and young adults with a substance use disorder	8
A phone-based tobacco use cessation program for people living with HIV in Uganda and Zambia: study protocol for a randomized controlled trial	8
Impact of the COVID-19 pandemic on burnout and perceived workplace quality among addiction treatment providers	8
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	8
Expanding access to addictions care: Implementation of a 24-hour healthcare provider support line in British Columbia, Canada	8
Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial	8
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	8
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	8
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	7
Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration	6
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	6
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	6
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	6
Feasibility and acceptability of incorporating social network visualizations into a culturally centered motivational network intervention to prevent substance use among urban Native American emerging	6
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	6
Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities	6
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people	6
Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report	6
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help?	6
Feasibility of a computer-assisted social network motivational interviewing intervention to reduce substance use and increase supportive connections among emerging adults transitioning from homelessne	6
The effects of neighborhood perceptions on response to a technology-assisted parenting intervention for adolescent substance use: protocol of a diversity supplement to parent SMART (Substance Misuse i	6
Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study	6
Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder	6

Proceedings of the 17th Annual International INEBRIA Conference	5
What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology	5
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	5
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	5
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	5
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy	5
Individual differences in treatment effects of internet-based cognitive behavioral therapy in primary care: a moderation analysis of a randomized clinical trial	5
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	5
Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study	5
Attitudes and training related to substance use in pediatric emergency departments	5
Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges	5
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	5
Alignment of substance use community benefit prioritization and service lines in US hospitals: a cross-sectional study	5
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	5
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers	5
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	5
Therapeutic community-oriented day treatment program for Korean women with alcohol use disorder: a non-randomized pilot feasibility trial	5
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	5
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	5
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs	5
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder	5
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	5
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	5
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting	5
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	5
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community	5
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper	4
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare	4
Case report: acute care management of severe opioid withdrawal with IV fentanyl	4
HIV pre-exposure prophylaxis programmatic preferences among people who inject drugs: findings from a discrete choice experiment	4
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	4
Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program	4
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study	4
Staff experiences of encountering and treating outpatients with substance use disorder in the psychiatric context: a qualitative study	4
Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran	4
Organization of primary care and early MOUD discontinuation	4
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use	4
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder	4
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany	4
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial	4
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu	4
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	4
Music therapy, neural processing, and craving reduction: an RCT protocol for a mixed methods feasibility study in a Community Substance Misuse Treatment Service	4
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population	4
Unveiling the roadblocks: exploring substance use disorder treatment policies in Iran through a qualitative lens	4
Alcohol consumption and dependence is linked to the extent that people experience need satisfaction while drinking alcohol in two Aboriginal and Torres Strait Islander communities	3
Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities	3
Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies	3
Physician blame and vulnerability: novel predictors of physician willingness to work with patients who misuse opioids	3
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model	3
Substance use recovery needs among college students seeking recovery services: a thematic qualitative analysis	3
Developing a Women’s Health track within addiction medicine fellowship: reflections and inspirations	3
Using practice facilitation to improve alcohol-related care in primary care: a mixed-methods pilot study protocol	3
Regaining control over alcohol intake but not abstinence on disulfiram medication, as a harm reduction approach: 2 case reports	3
Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping	3
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study	3
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors	3
Connect To Care (C2C): protocol for two-site randomized controlled pilot trial to improve outcomes for patients with hazardous drinking and PTSD and/or depression symptoms	3
Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial	3
Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention	3
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review	3
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	3
Introduction to the special series: using evidence to enhance health services for individuals using drugs in rural communities	3
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study	2
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education	2
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study	2
Using 42 CFR part 2 revisions to integrate substance use disorder treatment information into electronic health records at a safety net health system	2
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	2
Innovations to the ECHO model to enhance reach and network-building among addiction clinicians in Western Canada	2
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use	2
Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observation	2
Feasibility and acceptability of a web-intervention to prevent alcohol and cannabis-impaired driving among adolescents in driver education	2
‘Treat my whole person, not just my condition’: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs	2
Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial	2
A case of severe opioid and methamphetamine use disorder in a 14 year old	2
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review	2
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus	2
Should screening for risk of gambling-related harm be undertaken in health, care and support settings? A systematic review of the international evidence	2
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder	2
“It’s within your own power”: shared decision-making to support transitions to buprenorphine	2

GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study	2
Reasons for not seeking alcohol treatment among a sample of Florida adults with HIV who perceived the need for treatment	2
Preliminary study of alcohol problem severity and response to brief intervention	2
Centering autonomy and choice to support oral PrEP utilization among people who inject drugs: qualitative lessons from HPTN 094 INTEGRA	2
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa	2
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial	2
Exploring perceptions of genetic risk and the transmission of substance use disorders	2
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	2
Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital	2
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	2
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	2
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	2
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial	2
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff	2
Retention of people who inject drugs enrolled in a ‘medications for opioid use disorder’ (MOUD) programme in Uganda	2
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders	2
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs	2
More than three times as many Indigenous Australian clients at risk from drinking could be supported if clinicians used AUDIT-C instead of unstructured assessments	2
The validation and reliability of a Japanese version of the Problematic Online Gaming Questionnaire (POGQ-J)	2